Healthcare entity
Every one of those 2 sits in a single category, regulation. Kash Patel is most often covered alongside Department of Justice, which appears in 2 of these 2 stories. The 96-day window averages about 0.1 stories each week. They are better corroborated than the beat average, carrying 5.5 original sources each against 5.4 for the same window.
Last mentioned: Jul 11, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, regulation. Kash Patel is most often covered alongside Department of Justice, which appears in 2 of these 2 stories. The 96-day window averages about 0.1 stories each week. They are better corroborated than the beat average, carrying 5.5 original sources each against 5.4 for the same window. The average consequence score is 6.5, matching the 6.5 beat baseline for this window. We currently track 2 Healthcare stories that mention Kash Patel, published between March 25, 2026 and June 28, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 104 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Kash Patel. Shared-story counts are live from our verified record — not editorial picks.
New Federal Indictments
A major new wave of indictments is unsealed targeting specific citizens and firms for chemical delivery.
First Precursor Indictments
DOJ files first-ever charges against Chinese chemical companies for precursor trafficking.
China Schedules Fentanyl
China designates all fentanyl-related substances as controlled drugs following U.S. pressure.
The DOJ’s 14-day operation charges 455 defendants for $6.5 billion in fraudulent claims, exposing schemes from medically unnecessary tests to international masterminds. The crackdown signals an aggressive new era of enforcement that could reshape compliance across the healthcare sector.
Source: abcnews4.com · cbs12.com
The U.S. Department of Justice has indicted multiple Chinese citizens and companies for allegedly supplying the precursor chemicals used to manufacture fentanyl. This enforcement action targets the international origins of the synthetic opioid crisis, signaling a more aggressive extraterritorial approach by federal law enforcement.
Kash Patel is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
